Future of Pfizer stock

Hey guys,

what is the major takeaway on Pfizer stock? Time to sell or hold? Are they going to get vaxx approved for infants and booster every 6 months or going down with veritas videos exposing all the shit going on inside of the company?

2 Comments
 
Most Helpful

Project Veritas is not a credible source. You need only look at the ACORN debacle to figure that one out (their tactics ultimately resulted in the closure of ACORN). They selectively edit tape recordings to suit their own propaganda purposes, like they did in the Schiller/NPR tape that made it seem like they didn't want federal funding.

The allegations against Pfizer are more or less that they're gagging their scientists from talking about the efficacy of natural immunity against COVID-19, which to some extent is possibly true. It isn't in the company's best interest to discuss natural immunity when they can sell vaccines and booster vaccines to governments. With that being said, there are plenty of people across the glove who do not have natural immunity, so it stands to reason that they could make use of the immunity conferred by a Pfizer vaccine.

Even in the COVID crash, Pfizer stock had its lowest close on Mar. 20, 2020 with $27.48, which is 34.6% lower than prevailing market prices at time of writing. There was a lot of crap going down back then, and the stock price wasn't that far off from where it is. Much of the rest of the world is still unvaccinated, which leaves plenty of market potential even if boosters get disparaged. 

 

Qui deserunt voluptates delectus. Excepturi magnam perferendis eum.

Quo harum autem repellat sed. Dolorum sunt veniam atque impedit dolorem perferendis enim. Ea distinctio tenetur iure molestias culpa voluptatem. Veritatis laudantium dolorem non debitis porro maiores. Modi pariatur ratione recusandae quo sed animi.

Quia aliquid libero tenetur officiis et esse qui. Iure ullam voluptates enim non modi veritatis quod. Assumenda voluptate expedita architecto qui enim rerum. Adipisci cumque excepturi iusto nobis reprehenderit.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”